These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8471199)
1. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199 [TBL] [Abstract][Full Text] [Related]
2. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers. Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599 [TBL] [Abstract][Full Text] [Related]
3. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807 [TBL] [Abstract][Full Text] [Related]
4. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users. Herold M; Meise U; Günther V; Rössler H; Zangerle R Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316 [TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population. Diamondstone LS; Tollerud DJ; Fuchs D; Wachter H; Brown LM; Maloney E; Kurman CC; Nelson DL; Blattner WA J Clin Immunol; 1994 Nov; 14(6):368-74. PubMed ID: 7883864 [TBL] [Abstract][Full Text] [Related]
8. ["Prognostic markers" in serum of active and passive intravenous drug users infected with human immunodeficiency virus (HIV)]. Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Chodynicka B; Rogowski F; Kramarz P Pol Arch Med Wewn; 1995 Jun; 93(6):469-74. PubMed ID: 7491346 [TBL] [Abstract][Full Text] [Related]
9. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465 [TBL] [Abstract][Full Text] [Related]
10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
11. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology. Günther G; Haglund M; Lindquist L; Sköldenberg B; Forsgren M Scand J Infect Dis; 1996; 28(2):131-8. PubMed ID: 8792478 [TBL] [Abstract][Full Text] [Related]
13. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Hosp M; Elliott AM; Raynes JG; Mwinga AG; Luo N; Zangerle R; Pobee JO; Wachter H; Dierich MP; McAdam KP; Fuchs D Lung; 1997; 175(4):265-75. PubMed ID: 9195554 [TBL] [Abstract][Full Text] [Related]
14. Beta 2-microglobulin levels in drug users: the influence of risk behaviour. Flegg PJ; Brettle RP; Robertson JR; Clarkson RC; Bird AG AIDS; 1991 Aug; 5(8):1021-4. PubMed ID: 1777161 [TBL] [Abstract][Full Text] [Related]
15. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections. Carstens J; Andersen PL Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy. Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095 [TBL] [Abstract][Full Text] [Related]
17. Differences in laboratory values in HIV infection by sex, race, and risk group. Gorter RW; Vranizan KM; Osmond DH; Moss AR AIDS; 1992 Nov; 6(11):1341-7. PubMed ID: 1361747 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
19. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441 [TBL] [Abstract][Full Text] [Related]
20. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]